The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28).
about
Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-AnalysisPower Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors.Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA).CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis.Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritisAdvances and challenges in hemophilic arthropathy.Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.No further gain can be achieved by calculating Disease Activity Score in 28 joints with high-sensitivity assay of C-reactive protein because of high intraindividual variability of C-reactive protein: A cross-sectional study and theoretical consideraThe Reliability of Disease Activity Score in 28 Joints-C-Reactive Protein Might Be Overestimated in a Subgroup of Rheumatoid Arthritis Patients, When the Score Is Solely Based on Subjective Parameters: A Cross-sectional, Exploratory Study.Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis.The genetics of rheumatoid arthritis: new insights and implications.Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report.Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity
P2860
Q26769940-1699AB33-1213-4345-8F25-F0C089DF3035Q30825520-3E5305E5-A2F2-4C19-85D3-967C645C9C34Q35372388-0BB3E91E-363D-4842-BC57-5EBD08471A7AQ35555943-4BAD6D94-6F87-4283-BADE-794F87F8706BQ35744377-9453D8FF-90BA-460F-91D6-D24F489383F6Q37279529-FD1B3B2E-64C2-4B3A-AC1B-14D259A70669Q37309669-4D396972-59C9-4DB4-AA6E-1E56A3D8663DQ37582649-A054A58D-592F-48E4-A25C-B1B6EB456157Q37665023-1CB79192-27D4-4D5E-9DFD-EB53838BA1DFQ38648469-EC6B0816-C3B2-4852-8C27-52457CD8E9D8Q42336552-1E767EB2-E9DA-498E-8DA9-CAD6C14BF04AQ52564720-CF00E0F5-0020-49B7-9ECD-B873C33B43F5Q58699148-60F051BA-9DCB-4E85-A7E4-CC87AE6532E7
P2860
The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The development of the disease ...... using 28 joint counts (DAS28).
@en
type
label
The development of the disease ...... using 28 joint counts (DAS28).
@en
prefLabel
The development of the disease ...... using 28 joint counts (DAS28).
@en
P1476
The development of the disease ...... using 28 joint counts (DAS28).
@en
P2093
P L C M van Riel
P304
P433
5 Suppl 85
P577
2014-09-01T00:00:00Z